GLS1 is important in cancer development and progression [12–17], and its levels are increased in many tumors, including breast and prostate cancer and hepatocellular carcinoma (HCC) tissues, compared to normal tissues [17, 18]. The gene discussed is GLS; the disease is prostate cancer.